Advanced Diagnosis & Treatment for Kidney Cancer in Melbourne, FL

Advanced Diagnosis & Treatment for Kidney Cancer in Melbourne, FL

Board-certified urologists with 60+ combined years of experience providing comprehensive kidney cancer evaluation and treatment on the Space Coast.

Most Common Type:Renal Cell Carcinoma (85% of cases)
Peak Age Range:Adults 55-75
Early Detection Rate:Over 65% found incidentally on imaging
5-Year Survival (Localized):93% when caught early
Understanding Kidney Cancer

Understanding Kidney Cancer

Renal Cell Carcinoma and Other Kidney Malignancies

Kidney cancer occurs when abnormal cells in the kidney tissue grow uncontrollably, forming a mass or tumor. Renal cell carcinoma (RCC) is the most common type, accounting for approximately 85% of all kidney cancers in adults. The American Cancer Society estimates over 80,000 new cases are diagnosed annually in the United States, making it one of the ten most common cancers in both men and women.

At Zabinski Urology in Melbourne, FL, our urologists bring over 60 combined years of urological expertise to the diagnosis, staging, and management of kidney masses. Many kidney tumors are discovered incidentally during imaging for unrelated conditions, which underscores the importance of working with experienced urologists who can quickly determine the nature of a renal mass and recommend an appropriate treatment plan. Our practice serves patients throughout Palm Bay, Viera, Rockledge, Cocoa, Cocoa Beach, and Merritt Island.

What Increases Your Risk for Kidney Cancer?

What Increases Your Risk for Kidney Cancer?

Understanding the Factors That Contribute to Renal Cell Carcinoma

Kidney cancer develops when cells in the kidney undergo genetic mutations that cause them to multiply rapidly. While the exact trigger is not always identifiable, several well-established risk factors can increase a person's likelihood of developing renal cell carcinoma. Smoking doubles the risk compared to non-smokers, and the risk decreases gradually after quitting. Obesity is another significant contributor, as excess body weight alters hormone levels that may promote abnormal cell growth in the kidneys.

Chronic high blood pressure, whether treated or untreated, has been consistently linked to increased kidney cancer incidence. Occupational exposure to certain chemicals, including trichloroethylene and cadmium, also elevates risk. Patients with advanced chronic kidney disease, particularly those on long-term dialysis, face a higher probability of developing cystic changes that can become malignant. Additionally, certain inherited conditions such as Von Hippel-Lindau disease and hereditary papillary renal cell carcinoma carry a substantially increased risk. Men are diagnosed roughly twice as often as women, and incidence is highest among adults aged 55 to 75.

Kidney Cancer Staging and Prognosis

Kidney Cancer Staging and Prognosis

Why Early Detection Makes a Critical Difference

Kidney cancer staging determines the extent of disease and guides treatment decisions. Stage I tumors are confined to the kidney and measure 7 cm or less, while Stage II tumors are larger but still localized. Stage III indicates spread to nearby lymph nodes or major blood vessels, and Stage IV means the cancer has metastasized to distant organs such as the lungs, bones, or liver.

Prognosis varies significantly by stage at diagnosis. Localized kidney cancer (Stages I and II) carries a five-year relative survival rate of approximately 93%, highlighting the enormous benefit of early detection. Because many kidney tumors cause no symptoms in their early stages, incidental findings on abdominal imaging have become one of the most common paths to diagnosis. When symptoms do appear, they may include blood in the urine (hematuria), persistent flank pain, an abdominal mass, unexplained weight loss, or fatigue. At Zabinski Urology, we emphasize thorough diagnostic evaluation of any suspicious findings, ensuring patients receive timely and accurate staging so they can make informed treatment decisions.

What Causes Kidney Cancer?

What Causes Kidney Cancer?

Biological and Environmental Factors Behind Renal Malignancies

01

Tobacco Use

Smoking introduces carcinogens that are filtered through the kidneys, damaging renal cell DNA and doubling the risk of kidney cancer compared to non-smokers.

02

Obesity

Excess body fat alters hormonal balance and increases insulin-like growth factors, creating a cellular environment that promotes abnormal renal cell proliferation.

03

Chronic Hypertension

Sustained high blood pressure damages the kidney's delicate vascular system over time, increasing the likelihood of malignant cellular changes in renal tissue.

04

Genetic Predisposition

Inherited conditions like Von Hippel-Lindau disease and mutations in the VHL tumor suppressor gene significantly elevate lifetime kidney cancer risk.

05

Chemical Exposure

Workplace contact with substances like trichloroethylene, cadmium, and certain herbicides has been associated with increased renal cell carcinoma incidence.

06

Chronic Kidney Disease

Patients with long-term kidney dysfunction, especially those on dialysis, develop acquired cystic kidney disease that can progress to malignancy over time.

Why Choose Zabinski Urology for Kidney Cancer Care

Why Choose Zabinski Urology for Kidney Cancer Care

Father-Son Urology Team Serving Melbourne and the Space Coast

  • 60+ Years Combined Experience
  • Comprehensive Diagnostic Workup
  • Personalized Treatment Plans
  • Coordinated Oncology Care

Diagnostic and Monitoring Options at Zabinski Urology

How We Evaluate and Track Kidney Cancer

Procedure Best For Session Time Results Timeline Follow-Up
Cystoscopy Evaluating hematuria and ruling out bladder involvement 15-20 minutes Immediate visual findings As needed based on findings
Signs You May Need a Kidney Cancer Evaluation

Signs You May Need a Kidney Cancer Evaluation

Recognizing Symptoms That Warrant Urological Assessment

  • Blood in Urine
  • Persistent Flank Pain
  • Palpable Abdominal Mass
  • Unexplained Weight Loss
  • Chronic Fatigue
  • Incidental Imaging Finding

Frequently Asked Questions About Kidney Cancer

01 What are the early warning signs of kidney cancer?

Many kidney cancers produce no symptoms in early stages and are found incidentally on imaging studies. When symptoms do occur, the most common include blood in the urine (hematuria), persistent flank or back pain, a palpable mass in the abdomen, unexplained weight loss, and chronic fatigue. If you experience any of these, schedule an evaluation with a urologist promptly.

02 How is kidney cancer diagnosed?

Diagnosis typically begins with imaging studies such as CT scan, MRI, or ultrasound to identify and characterize a kidney mass. Additional tests may include blood work, urine analysis, and in some cases a renal biopsy. At Zabinski Urology, we also perform cystoscopy when hematuria is present to rule out bladder involvement and identify the source of bleeding.

03 What is the difference between a kidney cyst and kidney cancer?

Simple kidney cysts are very common, usually benign, and typically require no treatment. Complex cysts with irregular walls, septations, or solid components may require further evaluation as they carry a higher risk of malignancy. The Bosniak classification system helps urologists categorize cysts and determine whether monitoring, biopsy, or surgical intervention is needed.

04 What treatment options are available for kidney cancer?

Treatment depends on the stage, size, and type of tumor as well as your overall health. Options may include partial nephrectomy (removing only the tumor), radical nephrectomy (removing the entire kidney), active surveillance for small or slow-growing tumors, ablation therapies, and systemic treatments such as targeted therapy or immunotherapy for advanced disease. Your urologist will discuss the most appropriate approach for your situation.

05 Can you live a normal life with one kidney after surgery?

Yes. Most patients who undergo nephrectomy for kidney cancer live healthy, active lives with one functioning kidney. The remaining kidney typically compensates by increasing its filtration capacity. Regular follow-up monitoring of kidney function through blood tests is recommended, along with maintaining a healthy lifestyle to protect your remaining kidney.

06 How often should I be monitored after kidney cancer treatment?

Post-treatment surveillance typically includes imaging and lab work every 3 to 6 months for the first two years, then every 6 to 12 months for the next three years, and annually thereafter. The specific schedule depends on the stage of your cancer and the type of treatment you received. Our urologists will create a personalized follow-up plan for you.

07 Does Zabinski Urology perform kidney cancer surgery?

Zabinski Urology provides comprehensive kidney cancer evaluation, diagnosis, and staging. Depending on the specific surgical approach required, our urologists will either perform the procedure or coordinate with specialized surgical oncology colleagues to ensure you receive the most advanced surgical care available, while continuing to manage your pre-operative and post-operative urological care.

Location129 W Hibiscus Blvd, Suite D
Melbourne , FL, 32901

Schedule Your Consultation

Scientific References

  1. PubMed (PMID: 27157873) - Comprehensive review of renal cell carcinoma epidemiology, diagnosis, and management guidelines from the European Association of Urology.
  2. PubMed (PMID: 29331948) - AUA guidelines for management of the clinical T1 renal mass, including active surveillance and surgical intervention recommendations.
  3. PubMed (PMID: 31079028) - Updated outcomes data for partial versus radical nephrectomy demonstrating oncologic equivalence with improved renal function preservation.
  4. PubMed (PMID: 30191972) - Systematic review of risk factors for renal cell carcinoma including obesity, hypertension, and smoking as modifiable contributors.
  5. PubMed (PMID: 33227253) - NCCN Clinical Practice Guidelines in Oncology for kidney cancer providing evidence-based staging, treatment, and surveillance protocols.